Source:http://linkedlifedata.com/resource/pubmed/id/17177652
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-12-20
|
pubmed:abstractText |
Neo-angiogenesis may have an important role in the poor prognosis of gallbladder carcinoma. An enhanced expression of COX-2 was found in precancerous lesions and in gallbladder carcinoma, likely to be involved in carcinogenesis as well as in angiogenesis. To study the relationships between the COX-2 expression and degree of vascularization, as well as to evaluate their role in the prognosis of patients with gallbladder carcinoma. 27 cases of gallbladder adenocarcinoma were included, classified grading I-III according the WHO classification. The COX-2 and endothelial antigen CD105 expressions were assessed immunohistochemically. COX-2 expression was evaluated according to the percentage and staining intensity of positive cells into "COX-2 positive" and "COX-2 negative" groups. In order to assess tumor microvessel density (MVD), CD105 positively stained microvessels were counted for each specimen in predominantly vascular areas (hot spots) at 200 x magnification. The MVD ranged from 9 to 46 microvessels/field. 15 tumors belonged to the hypervascular group (MVD > or = 25) and 12 to the hypovascular group. There were 16 (59.2%) COX-2 positive cases. There was difference in the degree of angiogenesis between COX-2 positive vs. COX-2 negative group: 11 (68.8%) out of 16 "COX-2 positive" tumors were hypervascular, in comparison with just 4 (36.4%) of "COX-2 negative" tumors. Our data show that the MVD corresponds to the COX-2 overexpression in gallbladder carcinomas. Augmented tumor neovascularization induced by COX-2 might be responsible for the poor prognosis in gallbladder carcinoma patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1512-8601
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
58-63
|
pubmed:meshHeading |
pubmed-meshheading:17177652-Adenocarcinoma,
pubmed-meshheading:17177652-Aged,
pubmed-meshheading:17177652-Antigens, CD,
pubmed-meshheading:17177652-Cyclooxygenase 2,
pubmed-meshheading:17177652-Female,
pubmed-meshheading:17177652-Gallbladder Neoplasms,
pubmed-meshheading:17177652-Humans,
pubmed-meshheading:17177652-Immunohistochemistry,
pubmed-meshheading:17177652-Male,
pubmed-meshheading:17177652-Middle Aged,
pubmed-meshheading:17177652-Neovascularization, Pathologic,
pubmed-meshheading:17177652-Receptors, Cell Surface,
pubmed-meshheading:17177652-Regional Blood Flow,
pubmed-meshheading:17177652-Retrospective Studies
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas.
|
pubmed:affiliation |
Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
|
pubmed:publicationType |
Journal Article
|